Heart failure after myocardial infarction: Glass emptier than full

European Journal of Heart FailureVolume 25, Issue 8 p. 1225-1227 Invited Editorial Heart failure after myocardial infarction: Glass emptier than full Josephine Harrington, Josephine Harrington Division of Cardiology, Duke University Department of Medicine, Durham, NC, USA Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USASearch for more papers by this authorJaved Butler, Corresponding Author Javed Butler [email protected] Baylor Scott and White Research Institute, Dallas, TX, USA Department of Medicine, University of Mississippi, Jackson, MS, USA Corresponding author. Baylor Scott and White Research Institute, 3434 Live Oak, Dallas, TX 75204, USA. Tel: +1 214 820-2687, Email: [email protected]Search for more papers by this author Josephine Harrington, Josephine Harrington Division of Cardiology, Duke University Department of Medicine, Durham, NC, USA Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USASearch for more papers by this authorJaved Butler, Corresponding Author Javed Butler [email protected] Baylor Scott and White Research Institute, Dallas, TX, USA Department of Medicine, University of Mississippi, Jackson, MS, USA Corresponding author. Baylor Scott and White Research Institute, 3434 Live Oak, Dallas, TX 75204, USA. Tel: +1 214 820-2687, Email: [email protected]Search for more papers by this author First published: 18 July 2023 https://doi.org/10.1002/ejhf.2961Citations: 1 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2965. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Harrington J, Jones WS, Udell JA, Hannan K, Bhatt DL, Anker SD, et al. Acute decompensated heart failure in the setting of acute coronary syndrome. JACC Heart Fail. 2022; 10: 404–414. https://doi.org/10.1016/j.jchf.2022.02.008 2Greene SJ, Butler J, Fonarow GC. Contextualizing risk among patients with heart failure. JAMA. 2021; 326: 2261–2262. https://doi.org/10.1001/jama.2021.20739 3Harrington J, Petrie MC, Anker SD, Bhatt DL, Jones WS, Udell JA, et al. Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction: A review. JAMA Cardiol. 2022; 7: 1067–1075. https://doi.org/10.1001/jamacardio.2022.2847 4Filgueiras Filho NM, Feitosa Filho GS, Solla DJF, Argôlo FC, Guimarães PO, Paiva Filho IM, et al. Implementation of a regional network for ST-segment-elevation myocardial infarction (STEMI) care and 30-day mortality in a low to middle-income city in Brazil: Findings from Salvador's STEMI registry (RESISST). J Am Heart Assoc. 2018; 7:e008624. https://doi.org/10.1161/JAHA.118.008624 5Docherty KF, Jackson AM, Macartney M, Campbell RT, Petrie MC, Pfeffer MA, et al. Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016. Eur J Heart Fail. 2023; 25: 1213–1224. https://doi.org/10.1002/ejhf.2965 6Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, et al.; PARADISE-MI Investigators and Committees. Angiotensin receptor-neprilysin inhibition in acute myocardial infarction. N Engl J Med. 2021; 385: 1845–1855. https://doi.org/10.1056/NEJMoa2104508 7Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, et al. Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial. Am Heart J. 2022; 253: 86–98. https://doi.org/10.1016/j.ahj.2022.05.010 8 ClinicalTrials.gov. Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack (DAPA-MI). https://clinicaltrials.gov/ct2/show/NCT04564742. Accessed 30 June 2023 Citing Literature Volume25, Issue8August 2023Pages 1225-1227 ReferencesRelatedInformation